Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.099 | 0.08 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |